Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Nathan A BergerValerie C BessonA Hamid BoularesAlexander BürkleAlberto ChiarugiRobert S ClarkNicola J CurtinSalvatore CuzzocreaTed M DawsonValina L DawsonGyörgy HaskóLucas LiaudetFlavio MoroniPál PacherPeter RadermacherAndrew L SalzmanSolomon H SnyderFrancisco Garcia SorianoRobert P StrosznajderBalázs SümegiRaymond A SwansonCsaba Szabó

Published in: British journal of pharmacology (2017)

This article is part of a themed section on Inventing New Therapies Without Reinventing the Wheel: The Power of Drug Repurposing. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.2/issuetoc.

Keyphrases

dna damage
dna repair
rectal cancer
benign prostatic hyperplasia
lower urinary tract symptoms
robot assisted
stem cells
drug induced
oxidative stress
bone marrow
mesenchymal stem cells
cell therapy